AU2001296762B2 - Magnetic isolation and purification of nucleic acids - Google Patents
Magnetic isolation and purification of nucleic acids Download PDFInfo
- Publication number
- AU2001296762B2 AU2001296762B2 AU2001296762A AU2001296762A AU2001296762B2 AU 2001296762 B2 AU2001296762 B2 AU 2001296762B2 AU 2001296762 A AU2001296762 A AU 2001296762A AU 2001296762 A AU2001296762 A AU 2001296762A AU 2001296762 B2 AU2001296762 B2 AU 2001296762B2
- Authority
- AU
- Australia
- Prior art keywords
- nucleic acids
- magnetizable
- dna
- bound
- magnetizable cellulose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 101
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 101
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 101
- 238000002955 isolation Methods 0.000 title claims abstract description 15
- 238000000746 purification Methods 0.000 title claims abstract description 10
- 230000005291 magnetic effect Effects 0.000 title claims description 15
- 229920002678 cellulose Polymers 0.000 claims abstract description 118
- 239000001913 cellulose Substances 0.000 claims abstract description 117
- 238000000034 method Methods 0.000 claims abstract description 81
- 239000002245 particle Substances 0.000 claims abstract description 73
- 150000003839 salts Chemical class 0.000 claims abstract description 30
- 229920001515 polyalkylene glycol Polymers 0.000 claims abstract description 11
- 239000011534 wash buffer Substances 0.000 claims description 33
- 239000012149 elution buffer Substances 0.000 claims description 25
- 239000000243 solution Substances 0.000 claims description 23
- 239000000463 material Substances 0.000 claims description 20
- 239000002202 Polyethylene glycol Substances 0.000 claims description 14
- 229920001223 polyethylene glycol Polymers 0.000 claims description 14
- 230000001580 bacterial effect Effects 0.000 claims description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 11
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 10
- 239000013592 cell lysate Substances 0.000 claims description 8
- 239000003153 chemical reaction reagent Substances 0.000 claims description 7
- 241000282414 Homo sapiens Species 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 5
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 5
- 239000000872 buffer Substances 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 230000003612 virological effect Effects 0.000 claims description 4
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 239000006166 lysate Substances 0.000 claims description 3
- -1 polyethylene Polymers 0.000 claims description 3
- 150000007513 acids Chemical class 0.000 claims description 2
- 239000004698 Polyethylene Substances 0.000 claims 2
- 229920000573 polyethylene Polymers 0.000 claims 2
- 238000010828 elution Methods 0.000 claims 1
- 108020004414 DNA Proteins 0.000 description 89
- 239000012148 binding buffer Substances 0.000 description 20
- 238000007399 DNA isolation Methods 0.000 description 19
- 239000000203 mixture Substances 0.000 description 17
- 239000013612 plasmid Substances 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 15
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 239000013049 sediment Substances 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 12
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 108091006629 SLC13A2 Proteins 0.000 description 10
- 239000000523 sample Substances 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 9
- 108010067770 Endopeptidase K Proteins 0.000 description 8
- 239000008367 deionised water Substances 0.000 description 8
- 229910021641 deionized water Inorganic materials 0.000 description 8
- 239000012139 lysis buffer Substances 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000007983 Tris buffer Substances 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical group OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 6
- 238000000246 agarose gel electrophoresis Methods 0.000 description 5
- 210000004748 cultured cell Anatomy 0.000 description 5
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 108020000999 Viral RNA Proteins 0.000 description 4
- 210000004690 animal fin Anatomy 0.000 description 4
- 239000000356 contaminant Substances 0.000 description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 3
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 244000309466 calf Species 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 229920001281 polyalkylene Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 210000001541 thymus gland Anatomy 0.000 description 3
- 238000003260 vortexing Methods 0.000 description 3
- 241000219194 Arabidopsis Species 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 238000011143 downstream manufacturing Methods 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 235000011056 potassium acetate Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000651178 Homo sapiens Striated muscle preferentially expressed protein kinase Proteins 0.000 description 1
- 229910013470 LiC1 Inorganic materials 0.000 description 1
- 108091093105 Nuclear DNA Proteins 0.000 description 1
- 238000009004 PCR Kit Methods 0.000 description 1
- 238000011530 RNeasy Mini Kit Methods 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 102100027659 Striated muscle preferentially expressed protein kinase Human genes 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910000480 nickel oxide Inorganic materials 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- GNRSAWUEBMWBQH-UHFFFAOYSA-N oxonickel Chemical compound [Ni]=O GNRSAWUEBMWBQH-UHFFFAOYSA-N 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000007430 reference method Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- IOVGROKTTNBUGK-SJCJKPOMSA-N ritodrine Chemical compound N([C@@H](C)[C@H](O)C=1C=CC(O)=CC=1)CCC1=CC=C(O)C=C1 IOVGROKTTNBUGK-SJCJKPOMSA-N 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- KMIOJWCYOHBUJS-HAKPAVFJSA-N vorolanib Chemical compound C1N(C(=O)N(C)C)CC[C@@H]1NC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C KMIOJWCYOHBUJS-HAKPAVFJSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/1013—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by using magnetic beads
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26972901P | 2001-02-16 | 2001-02-16 | |
| US60/269,729 | 2001-02-16 | ||
| PCT/US2001/031637 WO2002066993A1 (en) | 2001-02-16 | 2001-10-05 | Magnetic isolation and purification of nucleic acids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2001296762A1 AU2001296762A1 (en) | 2003-02-27 |
| AU2001296762B2 true AU2001296762B2 (en) | 2007-03-15 |
Family
ID=23028437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001296762A Ceased AU2001296762B2 (en) | 2001-02-16 | 2001-10-05 | Magnetic isolation and purification of nucleic acids |
Country Status (8)
| Country | Link |
|---|---|
| EP (3) | EP2090655B1 (enExample) |
| JP (1) | JP4399164B2 (enExample) |
| AT (1) | ATE422542T1 (enExample) |
| AU (1) | AU2001296762B2 (enExample) |
| CA (1) | CA2438066A1 (enExample) |
| DE (1) | DE60137652D1 (enExample) |
| ES (1) | ES2322841T3 (enExample) |
| WO (1) | WO2002066993A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002333673B2 (en) * | 2001-11-06 | 2008-08-14 | Promega Corporation | Isolation and purification of nucleic acids |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7601497B2 (en) | 2000-06-15 | 2009-10-13 | Qiagen Gaithersburg, Inc. | Detection of nucleic acids by target-specific hybrid capture method |
| US6855499B1 (en) | 2001-02-16 | 2005-02-15 | Cortex Biochem, Inc. | Magnetic isolation and purification of nucleic acids |
| JP3983125B2 (ja) * | 2002-07-19 | 2007-09-26 | 富士フイルム株式会社 | 核酸の分離精製方法 |
| EP1510577A1 (en) * | 2003-08-29 | 2005-03-02 | Qiagen GmbH | Method for magnetic bead isolation of nucleic acids |
| EP1664295A4 (en) * | 2003-09-09 | 2007-12-05 | Fujifilm Corp | PROCESS FOR INSULATING AND PURIFYING NUCLEIC ACID |
| JP4284250B2 (ja) * | 2003-09-09 | 2009-06-24 | 富士フイルム株式会社 | 核酸分離精製方法 |
| US20050106602A1 (en) | 2003-11-17 | 2005-05-19 | Hashem Akhavan-Tafti | Simplified methods for isolating nucleic acids from cellular materials |
| US8426126B2 (en) * | 2004-03-18 | 2013-04-23 | Applied Biosystems, Llc | Modified surfaces as solid supports for nucleic acid purification |
| DE102007009347B4 (de) | 2007-02-27 | 2009-11-26 | Agowa Gmbh | Verfahren zur Isolierung von Nukleinsäuren |
| EP2157181A1 (de) | 2008-08-13 | 2010-02-24 | AGOWA Gesellschaft für molekularbiologische Technologie mbH | Verfahren zur Isolation von Nukleinsäuren und Testkit |
| TWI394839B (zh) | 2008-10-27 | 2013-05-01 | Qiagen Gaithersburg Inc | 快速結果雜交捕捉法及系統 |
| JP5738278B2 (ja) | 2009-05-01 | 2015-06-24 | キアジェン ゲイサーズバーグ インコーポレイテッド | 試料中のｒｎａスプライシング形態を検出するための非標的増幅法 |
| AU2010291990B2 (en) * | 2009-09-14 | 2016-05-05 | Qiagen Gaithersburg, Inc. | Compositions and methods for recovery of nucleic acids or proteins from tissue samples fixed in cytology media |
| US9605303B2 (en) | 2010-01-29 | 2017-03-28 | Qiagen Gaithersburg, Inc. | Method of determining and confirming the presence of an HPV in a sample |
| EP2528932B1 (en) | 2010-01-29 | 2016-11-30 | QIAGEN Gaithersburg, Inc. | Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids |
| CA2799200A1 (en) | 2010-05-19 | 2011-11-24 | Qiagen Gaithersburg, Inc. | Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids |
| EP2576840B1 (en) | 2010-05-25 | 2018-10-17 | QIAGEN Gaithersburg, Inc. | Fast results hybrid capture assay and associated strategically-truncated probes |
| US9885092B2 (en) | 2011-02-24 | 2018-02-06 | Qiagen Gaithersburg Inc. | Materials and methods for detection of HPV nucleic acids |
| DE102012012523B4 (de) | 2012-06-26 | 2015-02-12 | Magnamedics Gmbh | Reinigung von Nukleinsäuren |
| EP3447141B1 (en) | 2013-03-18 | 2020-08-05 | PreAnalytiX GmbH | Stabilisation of biological samples |
| JP6736463B2 (ja) | 2013-12-02 | 2020-08-05 | バイオカーティス エヌ ヴイ | 循環核酸の抽出 |
| EP3218480A1 (en) | 2014-11-14 | 2017-09-20 | Corning Incorporated | Methods and kits for post-ivt rna purification |
| US20180135040A1 (en) | 2016-02-16 | 2018-05-17 | Life Magnetics, Inc. | Methods for separating nucleic acids with graphene coated magnetic beads |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8507706D0 (en) * | 1985-03-25 | 1985-05-01 | Genetics Int Inc | Magnetic nucleic acid sequences |
| US4921805A (en) * | 1987-07-29 | 1990-05-01 | Life Technologies, Inc. | Nucleic acid capture method |
| US5234809A (en) | 1989-03-23 | 1993-08-10 | Akzo N.V. | Process for isolating nucleic acid |
| EP0411944B1 (en) * | 1989-08-04 | 1998-06-10 | BEHRINGWERKE Aktiengesellschaft | Heterogeneous binding assays |
| GB9003253D0 (en) | 1990-02-13 | 1990-04-11 | Amersham Int Plc | Precipitating polymers |
| US5705628A (en) | 1994-09-20 | 1998-01-06 | Whitehead Institute For Biomedical Research | DNA purification and isolation using magnetic particles |
| US6027945A (en) | 1997-01-21 | 2000-02-22 | Promega Corporation | Methods of isolating biological target materials using silica magnetic particles |
-
2001
- 2001-10-05 WO PCT/US2001/031637 patent/WO2002066993A1/en not_active Ceased
- 2001-10-05 JP JP2002566667A patent/JP4399164B2/ja not_active Expired - Lifetime
- 2001-10-05 EP EP08021881.1A patent/EP2090655B1/en not_active Expired - Lifetime
- 2001-10-05 CA CA002438066A patent/CA2438066A1/en not_active Abandoned
- 2001-10-05 AU AU2001296762A patent/AU2001296762B2/en not_active Ceased
- 2001-10-05 EP EP10176947.9A patent/EP2363476B1/en not_active Expired - Lifetime
- 2001-10-05 ES ES01977661T patent/ES2322841T3/es not_active Expired - Lifetime
- 2001-10-05 AT AT01977661T patent/ATE422542T1/de not_active IP Right Cessation
- 2001-10-05 EP EP01977661A patent/EP1368629B1/en not_active Expired - Lifetime
- 2001-10-05 DE DE60137652T patent/DE60137652D1/de not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002333673B2 (en) * | 2001-11-06 | 2008-08-14 | Promega Corporation | Isolation and purification of nucleic acids |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2322841T3 (es) | 2009-06-30 |
| JP4399164B2 (ja) | 2010-01-13 |
| EP2090655B1 (en) | 2013-05-08 |
| ATE422542T1 (de) | 2009-02-15 |
| EP2090655A1 (en) | 2009-08-19 |
| WO2002066993A1 (en) | 2002-08-29 |
| EP1368629A4 (en) | 2005-07-06 |
| EP2363476A1 (en) | 2011-09-07 |
| JP2004523238A (ja) | 2004-08-05 |
| EP1368629B1 (en) | 2009-02-11 |
| DE60137652D1 (de) | 2009-03-26 |
| EP1368629A1 (en) | 2003-12-10 |
| EP2363476B1 (en) | 2013-05-29 |
| CA2438066A1 (en) | 2002-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001296762B2 (en) | Magnetic isolation and purification of nucleic acids | |
| US6855499B1 (en) | Magnetic isolation and purification of nucleic acids | |
| AU2001296762A1 (en) | Magnetic isolation and purification of nucleic acids | |
| AU2002333673B2 (en) | Isolation and purification of nucleic acids | |
| KR100623184B1 (ko) | 임의의 복잡한 출발물질로부터 핵산을 분리하기 위한배합물과 방법 그리고 복합한 유전자 분석법 | |
| JP6207119B2 (ja) | 核酸の精製法 | |
| Surzycki | Basic techniques in molecular biology | |
| US9464316B2 (en) | Method for isolating nucleic acids comprising the use of ethylene glycol multimers | |
| US7560228B2 (en) | Solid-phase nucleic acid isolation | |
| KR100692941B1 (ko) | 핵산의 고체상으로의 흡착 | |
| US20100121044A1 (en) | Solid phase technique for selectively isolating nucleic acids | |
| AU2002333673A1 (en) | Isolation and purification of nucleic acids | |
| WO2022008591A1 (en) | Method for isolating nucleic acid | |
| US20040137449A1 (en) | Magnetic isolation and purification of nucleic acids | |
| EP2094846A1 (en) | Use of tde for the isolation of nucleic acids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| PC | Assignment registered |
Owner name: PROMEGA CORPORATION Free format text: FORMER OWNER WAS: CORTEX BIOCHEM, INC. |
|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |